Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China

[1]  C. Walker,et al.  Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia , 2018, Brain : a journal of neurology.

[2]  V. Shoshan-Barmatz,et al.  VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis. , 2018, Current medicinal chemistry.

[3]  David S. Park,et al.  Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases , 2017, Cell Death & Differentiation.

[4]  A. Brice,et al.  Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias , 2017, European Journal of Human Genetics.

[5]  C. Hoogenraad,et al.  Dynamic Palmitoylation Targets MAP6 to the Axon to Promote Microtubule Stabilization during Neuronal Polarization , 2017, Neuron.

[6]  D. Timmann,et al.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78) , 2017, Brain : a journal of neurology.

[7]  A. Oliveira,et al.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks , 2016, The Cerebellum.

[8]  V. Shoshan-Barmatz,et al.  Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation. , 2016, Biochimica et biophysica acta.

[9]  J. Bouchard,et al.  SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases , 2015, European Journal of Human Genetics.

[10]  A. Singleton,et al.  Genetic and phenotypic characterization of complex hereditary spastic paraplegia , 2016, Brain : a journal of neurology.

[11]  Zacharias Kohl,et al.  Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients , 2016, Annals of neurology.

[12]  F. Gage,et al.  GSK3ß‐dependent dysregulation of neurodevelopment in SPG11‐patient induced pluripotent stem cell model , 2016, Annals of neurology.

[13]  Sangeeta Khare,et al.  Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .

[14]  A. Mackay-Sim,et al.  A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations , 2015, Disease Models & Mechanisms.

[15]  J. Solowska,et al.  Hereditary spastic paraplegia SPG4: what is known and not known about the disease. , 2015, Brain : a journal of neurology.

[16]  M. Damme,et al.  In Vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11 , 2015, PLoS genetics.

[17]  G. Stevanin,et al.  Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology , 2015, Human Genetics.

[18]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[19]  C. Blackstone,et al.  Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. , 2014, The Journal of clinical investigation.

[20]  F. Santorelli,et al.  Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms , 2014, Experimental Neurology.

[21]  R. Tortelli,et al.  A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness , 2014, Journal of the Neurological Sciences.

[22]  A. Vanderver,et al.  Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11 , 2014, Annals of clinical and translational neurology.

[23]  U. Schlötzer-Schrehardt,et al.  Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia , 2014, Human molecular genetics.

[24]  Paula Coutinho,et al.  The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies , 2014, Neuroepidemiology.

[25]  C. Blackstone,et al.  Loss of Spastin Function Results in Disease‐Specific Axonal Defects in Human Pluripotent Stem Cell‐Based Models of Hereditary Spastic Paraplegia , 2014, Stem cells.

[26]  F. Gage,et al.  Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients’ neurons , 2013, Human molecular genetics.

[27]  A. Ballabio,et al.  Defective autophagy in spastizin mutated patients with hereditary spastic paraparesis type 15. , 2013, Brain : a journal of neurology.

[28]  J. Fink,et al.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms , 2013, Acta Neuropathologica.

[29]  A. Mackay-Sim,et al.  A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations , 2012, Disease Models & Mechanisms.

[30]  A. Destée,et al.  Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. , 2012, Brain : a journal of neurology.

[31]  D. Bourdette,et al.  Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases , 2012, Molecular Neurodegeneration.

[32]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[33]  G. Bernardi,et al.  Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation , 2011, Journal of Neurology.

[34]  M. Demirci.  Comprehensive Clinical Nephrology 3rd Edition , 2011 .

[35]  A. Durr,et al.  CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. , 2009, Brain : a journal of neurology.

[36]  M. Shoukier,et al.  Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia , 2009, European Journal of Human Genetics.

[37]  A. Durr,et al.  Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10 , 2009, Human mutation.

[38]  P. Coutinho,et al.  Novel SPG3A and SPG4 mutations in dominant spastic paraplegia families , 2009, Acta neurologica Scandinavica.

[39]  S. Klebe,et al.  Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia , 2009, neurogenetics.

[40]  Christos Proukakis,et al.  Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms , 2008, The Lancet Neurology.

[41]  N. Wood,et al.  Clinical heterogeneity and genotype‐phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations (SPG11) , 2008, European journal of neurology.

[42]  J. Masdeu,et al.  SPG11 compound mutations in spastic paraparesis with thin corpus callosum , 2008, Neurology.

[43]  Huey-Ling Chen,et al.  Neonatal Cholestatic Liver Disease in an Asian Patient With a Homozygous Mutation in the Oxysterol 7α-hydroxylase Gene , 2008, Journal of pediatric gastroenterology and nutrition.

[44]  F. Pasquier,et al.  Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. , 2008, Brain : a journal of neurology.

[45]  B. Himes,et al.  Quantitative and Functional Analyses of Spastin in the Nervous System: Implications for Hereditary Spastic Paraplegia , 2008, The Journal of Neuroscience.

[46]  Andrew H Crosby,et al.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. , 2008, American journal of human genetics.

[47]  P. Hedera,et al.  Infantile onset of hereditary spastic paraplegia poorly predicts the genotype. , 2007, Pediatric neurology.

[48]  M. Ruberg,et al.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum , 2007, Nature Genetics.

[49]  O. Witte,et al.  High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia , 2006, Neurology.

[50]  M. Black,et al.  Effects of Dynactin Disruption and Dynein Depletion on Axonal Microtubules , 2006, Traffic.

[51]  J. Shaw,et al.  Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. , 2005, Annual review of genetics.

[52]  L. Qiang,et al.  Microtubules cut and run. , 2005, Trends in cell biology.

[53]  Christopher J McDermott,et al.  Hereditary spastic paraparesis: Disrupted intracellular transport associated with spastin mutation , 2003, Annals of neurology.

[54]  S. Wharton,et al.  The Cellular and Molecular Pathology of the Motor System in Hereditary Spastic Paraparesis due to Mutation of the Spastin Gene , 2003, Journal of neuropathology and experimental neurology.

[55]  G. Rouleau,et al.  Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. , 2002, Archives of neurology.

[56]  M. Pericak-Vance,et al.  Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. , 2001, American journal of human genetics.

[57]  Bertrand Fontaine,et al.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia , 1999, Nature Genetics.

[58]  A. Harding.  CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[59]  Pask Ea,et al.  HOMOSEXUALITY AS A CRIME. , 1965 .